Aimz Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Aimz Investment Advisors, LLC

$289 Million
Q3 2024

A detailed history of Aimz Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aimz Investment Advisors, LLC holds 53,249 shares of BMY stock, worth $3.1 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

53,249

Previous 53,419 0.32%

Holding current value

$3.1 Million

Previous $2.22 Million 24.21%

% of portfolio

0.95%

Previous 0.8%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $6,742 - $8,797	-170 Reduced 0.32%	53,249 $2.76 Million
Q2 2024 Aug 07, 2024	BUY	$40.25 - $52.99 $32,159 - $42,339	799 Added 1.52%	53,419 $2.22 Million
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $5,037 - $5,712	105 Added 0.2%	52,620 $2.85 Million
Q4 2023 Jan 26, 2024	BUY	$48.48 - $57.85 $97,153 - $115,931	2,004 Added 3.97%	52,515 $2.69 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $15,861 - $17,736	-274 Reduced 0.54%	50,511 $2.93 Million
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $6,179 - $6,861	-97 Reduced 0.19%	50,785 $3.25 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $58,941 - $66,853	-897 Reduced 1.73%	50,882 $3.53 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $35,404 - $41,923	-517 Reduced 0.99%	51,779 $3.73 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $3 - $2,074	27 Added 0.05%	52,296 $3.72 Million
Q2 2022 Aug 02, 2022	BUY	$72.62 - $79.98 $217 - $239	3 Added 0.01%	52,269 $4.03 Million
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $106,852 - $128,125	-1,738 Reduced 3.22%	52,266 $3.82 Million
Q4 2021 Feb 09, 2022	BUY	$53.63 - $62.52 $99,376 - $115,849	1,853 Added 3.55%	54,004 $3.37 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $608,740 - $713,061	10,288 Added 24.58%	52,151 $3.09 Million
Q2 2021 Aug 05, 2021	BUY	$61.91 - $67.42 $185 - $202	3 Added 0.01%	41,863 $2.8 Million
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $15,013 - $16,885	-253 Reduced 0.6%	41,860 $2.64 Million
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $8,372 - $9,487	-145 Reduced 0.34%	42,113 $2.61 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $34,113 - $37,802	-594 Reduced 1.39%	42,258 $2.55 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $45,500 - $53,194	830 Added 1.98%	42,852 $2.52 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $232 - $337	5 Added 0.01%	42,022 $2.34 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $1.83 Million - $2.38 Million	37,155 Added 764.19%	42,017 $2.7 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $9,623 - $11,409	-225 Reduced 4.42%	4,862 $247,000
Q2 2017 Aug 15, 2017	BUY	N/A	5,087	5,087 $283,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aimz Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aimz Investment Advisors, LLC with notifications on news.

Account

Aimz Investment Advisors, LLC Bristol Myers Squibb CO Transaction History